Crescent Biopharma Inc. (CBIO)
CBIO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$12.91
-10.72% on the day
Market cap
$479.5M
Small cap
Revenue · 2025
$10.8M
No prior year to compare
Net income · 2025
$154K
1.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CBIO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001253689 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | E9 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $10.8M |
| Net income | $154K |
| Operating income | -$152.6M |
| Net margin | 1.4% |
| Operating margin | -1407.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $213.2M |
| Total assets | $240.3M |
| P/E (computed) | 3115.0× |
| P/S (computed) | 44.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2026-07-30 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-07-30 |
| Latest current report | 8-K | 2026-07-30 |
| Latest proxy | DEFA14A | 2026-04-21 |
Source: SEC EDGAR submissions feed, 674 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.9% |
| 1 month | -32.5% |
| 3 months | -16.0% |
| Year to date | +7.0% |
| 1 year | +23.8% |
| From 52-week high | -53.0% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| EVO | Evotec SE | $1.34 | -1.82% | $478.5M |
| MNPR | Monopar Therapeutics Inc. | $72.08 | -6.45% | $483.8M |
| ALT | Altimmune Inc. | $2.43 | -5.08% | $472.7M |
| OCS | Oculis Holding AG | $7.62 | -3.30% | $469.3M |
| BLSM | BlossomHill Therapeutics Inc. | $15.48 | -10.37% | $492.0M |
| EOLS | Evolus Inc. | $7.51 | -3.10% | $496.0M |
| DRUG | Bright Minds Biosciences Inc. | $51.36 | -4.91% | $504.3M |
| CTMX | CytomX Therapeutics Inc. | $2.33 | -3.93% | $506.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier